Skip to main content

Charles River Laboratories cash flow statement

  • CRL · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$337.97−0.83%Close 13 Nov 2026 · Market value $16.04B

In fiscal 2025 (the year to 27 Dec 2025), Charles River Laboratories generated $737.6M of operating cash flow and $518.5M of free cash flow, after $219.2M of capital expenditure.

From Charles River Laboratories's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 27 Dec 2025. TTM is the last four reported quarters added up.

Annual

Charles River Laboratories cash flow statement, annual
USDFY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income−$524.5M$114.4M−$336.7M$109.6M$97.30M$102.8M$126.7M$149.3M$154.8M$123.4M$226.4M$252.0M$364.3M$391.0M$486.2M$474.6M$22.20M−$144.3M$40.19M
Depreciation & amortization$86.85M$89.96M$93.65M$85.23M$81.28M$96.64M$96.44M$94.88M$126.7M$131.2M$161.8M$198.1M$234.9M$265.5M$303.9M$314.1M$361.7M$403.3M$285.0M
Stock-based compensation$24.21M$23.65M$25.53M$21.71M$21.86M$24.54M$31.04M$40.12M$43.64M$44.00M$47.35M$57.27M$56.34M$71.47M$73.62M$72.05M$69.89M$71.08M$80.56M
Operating cash flow$282.7M$225.0M$169.0M$205.3M$208.0M$207.1M$251.1M$305.0M$316.9M$318.1M$441.1M$480.9M$546.6M$760.8M$619.6M$683.9M$734.6M$737.6M$622.4M
Operating cash flow margin21.8%19.2%14.9%18.0%18.4%17.8%19.3%22.4%18.8%17.1%19.5%18.3%18.7%21.5%15.6%16.6%18.1%18.4%15.7%
Capital expenditures$198.6M$79.85M$42.86M$49.14M$47.53M$39.15M$56.92M$63.25M$55.29M$82.43M$140.1M$140.5M$166.6M$228.8M$324.7M$318.5M$233.0M$219.2M$222.8M
Acquisitions$69.15M$83.35M$0.00$0.00$16.86M$29.22M$234.3M$247.7M$648.5M$25.01M$824.9M$515.7M$418.6M$1.29B$283.4M$194.8M$5.48M$0.00$467.3M
Free cash flow$84.08M$145.2M$126.2M$156.1M$160.5M$168.0M$194.1M$241.7M$261.6M$235.6M$301.1M$340.4M$380.0M$532.0M$294.9M$365.4M$501.6M$518.5M$399.6M
Free cash flow margin6.5%12.4%11.1%13.7%14.2%14.4%15.0%17.7%15.6%12.7%13.3%13.0%13.0%15.0%7.4%8.8%12.4%12.9%10.0%
Free cash flow per share$1.25$2.21$2.02$3.04$3.32$3.46$4.08$5.07$5.46$4.85$6.14$6.85$7.51$10.35$5.75$7.10$9.72$10.46$8.21
Gross share repurchases$115.1M$45.90M$356.5M$283.8M$64.19M$165.9M$122.0M$117.5M$12.27M$106.9M$13.85M$18.09M$23.98M$40.71M$38.65M$24.16M$119.2M$360.7M$324.2M
Stock issuance proceeds————$18.43M$93.82M$73.69M$39.37M$23.20M$38.87M$37.66M$34.55M$46.59M$45.65M$25.11M$25.60M$23.88M$714.0K$30.44M
Net share repurchases$115.1M$45.90M$356.5M$283.8M$45.76M$72.11M$48.33M$78.11M−$10.93M$68.04M−$23.81M−$16.46M−$22.61M−$4.95M$13.54M−$1.44M$95.30M$360.0M$293.8M
Cash interest paid$14.19M$8.10M$16.14M$22.32M$15.14M$12.03M$10.20M$11.10M$22.76M$27.42M$47.54M$67.81M$72.46M$70.78M$100.8M$132.1M$123.5M$101.7M$102.8M
Free cash flow after SBC$59.87M$121.5M$100.6M$134.4M$138.6M$143.4M$163.1M$201.6M$218.0M$191.6M$253.7M$283.2M$323.7M$460.6M$221.3M$293.3M$431.7M$447.4M$319.1M

Quarterly

Charles River Laboratories cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$187.1M$72.96M$94.08M$69.66M−$214.5M$25.47M$52.33M$54.42M−$276.6M−$14.84M−$1.48M$333.1M
Depreciation & amortization$80.51M$85.36M$86.08M$88.20M$102.1M$120.4M$119.5M$85.16M$78.28M$67.15M$67.29M$72.26M
Stock-based compensation$19.52M$16.74M$16.59M$19.33M$17.23M$13.13M$17.05M$23.27M$17.63M$22.38M$19.78M$20.77M
Operating cash flow$220.9M$129.9M$193.5M$251.8M$159.4M$171.7M$204.6M$213.8M$147.5M$41.08M$179.7M$254.1M
Operating cash flow margin21.8%12.8%18.9%24.9%15.9%17.4%19.8%21.3%14.8%4.1%17.9%25.9%
Capital expenditures$78.32M$79.14M$39.49M$38.72M$75.62M$59.32M$35.30M$35.58M$88.95M$55.91M$31.11M$46.81M
Acquisitions$144.6M$0.00$5.48M$0.00$0.00$0.00$0.00$0.00$0.00$405.0M$62.25M$0.00
Free cash flow$142.6M$50.74M$154.0M$213.1M$83.75M$112.4M$169.3M$178.2M$58.57M−$14.83M$148.6M$207.3M
Free cash flow margin14.1%5.0%15.0%21.1%8.4%11.4%16.4%17.7%5.9%−1.5%14.8%21.1%
Free cash flow per share$2.78$0.98$2.97$4.13$1.63$2.21$3.43$3.61$1.19−$0.30$3.09$4.27
Gross share repurchases$139.0K$9.35M$8.91M$100.8M$124.0K$353.1M$7.35M$93.00K$96.00K$208.3M$115.6M$224.0K
Stock issuance proceeds$5.94M$21.50M$826.0K$779.0K$768.0K$0.00$1.00K$2.00K$711.0K$1.22M$397.0K$28.11M
Net share repurchases−$5.80M−$12.15M$8.09M$100.0M−$644.0K$353.1M$7.35M$91.00K−$615.0K$207.1M$115.2M−$27.89M
Cash interest paid$26.09M$38.26M$27.37M$32.94M$24.88M$29.09M$26.03M$28.29M$18.31M$28.99M$24.21M$31.33M
Free cash flow after SBC$123.1M$34.01M$137.5M$193.7M$66.51M$99.24M$152.3M$155.0M$40.94M−$37.21M$128.8M$186.5M

The main figures as JSON and plain text. See data and methodology.

CRL in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.